These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 7926514)
1. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Hussaini SH; Murphy GM; Kennedy C; Besser GM; Wass JA; Dowling RH Gastroenterology; 1994 Nov; 107(5):1503-13. PubMed ID: 7926514 [TBL] [Abstract][Full Text] [Related]
5. Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones. Hussaini SH; Pereira SP; Veysey MJ; Kennedy C; Jenkins P; Murphy GM; Wass JA; Dowling RH Gut; 1996 May; 38(5):775-83. PubMed ID: 8707128 [TBL] [Abstract][Full Text] [Related]
6. Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly. A prospective study. Erlinger S; Chanson P; Dumont M; Ponsot P; Warnet A; Harris AG Dig Dis Sci; 1994 Nov; 39(11):2384-8. PubMed ID: 7956607 [TBL] [Abstract][Full Text] [Related]
7. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones. Gustafsson U; Sahlin S; Einarsson C Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325 [TBL] [Abstract][Full Text] [Related]
9. Deoxycholic acid is not related to lithogenic factors in gallbladder bile. Jüngst D; Müller I; Kullak-Ublick GA; Meyer G; Frimberger E; Fischer S J Lab Clin Med; 1999 Apr; 133(4):370-7. PubMed ID: 10218768 [TBL] [Abstract][Full Text] [Related]
10. Cholelithiasis and acromegaly: therapeutic strategies. Montini M; Gianola D; Pagani MD; Pedroncelli A; Caldara R; Gherardi F; Bonelli M; Lancranjan I; Pagani G Clin Endocrinol (Oxf); 1994 Mar; 40(3):401-6. PubMed ID: 8187305 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of the long-term effects of somatostatin analog (octreotide) on gallbladder function and gallstone formation in Chinese acromegalic patients. Shi YF; Zhu XF; Harris AG; Zhang JX; Dai Q J Clin Endocrinol Metab; 1993 Jan; 76(1):32-7. PubMed ID: 8421099 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones. Jüngst D; Lang T; von Ritter C; Pratschke E; Paumgartner G Hepatology; 1992 May; 15(5):804-8. PubMed ID: 1568721 [TBL] [Abstract][Full Text] [Related]
13. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones. Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215 [TBL] [Abstract][Full Text] [Related]
17. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Portincasa P; Di Ciaula A; Vendemiale G; Palmieri V; Moschetta A; Vanberge-Henegouwen GP; Palasciano G Eur J Clin Invest; 2000 Apr; 30(4):317-24. PubMed ID: 10759880 [TBL] [Abstract][Full Text] [Related]
18. Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly. Catnach SM; Anderson JV; Fairclough PD; Trembath RC; Wilson PA; Parker E; Besser GM; Wass JA Gut; 1993 Feb; 34(2):270-3. PubMed ID: 8432484 [TBL] [Abstract][Full Text] [Related]
19. The effect of ursodeoxycholic acid on nucleation time in patients with solitary or multiple gallbladder stones. Tudyka J; Wechsler JG; Mason R; Maier C Am J Gastroenterol; 1994 Aug; 89(8):1206-10. PubMed ID: 8053436 [TBL] [Abstract][Full Text] [Related]
20. Bile acid and phospholipid fatty acid composition in bile of patients with cholesterol and pigment gallstones. van Erpecum KJ; van Berge Henegouwen GP; Stolk MF Clin Chim Acta; 1991 Jul; 199(3):295-303. PubMed ID: 1769113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]